David Rotman

A View from David Rotman

Synthetic Bio Debate

  • June 30, 2006

Those interested in truly understanding the potential bioterror dangers of the emerging field of synthetic biology should make sure they read and keep updated on the discussion surrounding the Declaration of the Second International Meeting on Synthetic Biology. In this statement, which resulted from a conference attended by some 300 researchers, lawyers, and government policy types, experts in synthetic biology spelled out realistic concerns and suggested ways to go forward.

Also worth tracking is the controversy in the synthetic biology community over a newspaper article in The Guardian that led off with the teaser: “DNA sequences from some of the most deadly pathogens known to man can be bought over the Internet, the Guardian has discovered.” A well-argued critique by Rob Carlson can be found at his website.

On Wednesday, Technologyreview.com will run a Q&A with Drew Endy, a biological engineer at MIT and leading proponent of synthetic biology, asking him about these debates and how to safely proceed with synthetic biology research.

The latest Insider Conversation is live! Listen to the story behind the story.

Subscribe today
Already a Premium subscriber? Log in.

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

Want more award-winning journalism? Subscribe to Insider Basic.
  • Insider Basic {! insider.prices.basic !}*

    {! insider.display.menuOptionsLabel !}

    Six issues of our award winning magazine and daily delivery of The Download, our newsletter of what’s important in technology and innovation.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.